Dishman Carbogen Amcis Q3 Result 2024: Date and Time, Share Price and Target

News: Dishman Carbogen Amcis Ltd. is a pharmaceutical company based in India. They are involved in the production of active pharmaceutical ingredients (APIs), intermediates, and specialized chemicals. Their work contributes to the healthcare industry by supporting drug development and manufacturing.

Why Are Q3 Results Important?

Quarterly results provide insights into a company’s financial health and performance during a specific three-month period. Investors, analysts, and stakeholders closely monitor these results to assess growth, profitability, and overall business stability.

When Is the Q3 Result Announcement?

Dishman Carbogen Amcis is set to announce its Q3 results on February 14, 2024. This date is crucial for investors as it reveals how the company performed from October to December 2023.

What Can We Expect?

While I don’t have a crystal ball, let’s look at some key metrics and trends:

1. Share Price: As of the last update, Dishman Carbogen Amcis’ share price was ₹201.70. Investors will be keen to see if there are any significant changes after the Q3 results.
2. Revenue Performance: The company experienced a QoQ revenue decline of 18.47% in the previous quarter, which was the lowest in the last three years. Analysts will analyze whether this trend continues or if there’s a rebound.
3. Annual Growth: Dishman Carbogen’s annual revenue growth of 11.75% outperformed its three-year compound annual growth rate (CAGR) of 5.28%. Investors will watch if this growth trajectory continues.

Subscribe to Sarkari Result to stay informed. Get the latest celebrity news and detailed movie reviews in real-time. Keep up with the constantly changing world of entertainment with Sarkari Exam.

About Dishman Carbogen Amcis Ltd :

Dishman Carbogen Amcis Ltd is a leading pharmaceutical company with a global presence. Let’s dive into what makes this company special:

Mission and Vision

Mission is to improve lives by partnering with the pharmaceutical and biopharmaceutical industries. We’ve been doing this for over 30 years, helping our clients develop and bring new drugs to market. Vision is to be the go-to partner for complex and challenging substances, highly potent active ingredients, and innovative vitamin, healthcare, and industrial products.

What Do

1. Drug Development Support: They assist in drug development, minimizing risks and reducing time associated with the process.
2. Contract Manufacturing: They provide long-term and value-added contract manufacturing solutions.
3. Active Ingredients: Their expertise lies in manufacturing active ingredients for pharmaceuticals.
4. Global Reach: With a presence in Switzerland, the UK, Europe, China, and other countries, we serve clients worldwide.

Why Choose Dishman Carbogen Amcis Ltd?

• Operational Excellence: They focus on reducing risks and ensuring efficient chemical development and commercial manufacturing.
• Client Satisfaction: Goal is to make our clients’ lives easier by delivering quality solutions.
• Innovation: Break new ground with our innovative products.

Investors should keep a close eye on the stock market and consider adding Dishman Carbogen Amcis to their watchlist. The Q3 results will provide valuable information for making informed investment decisions.

Disclaimer: Please note that all content and tools on this website are provided for your convenience and are offered “as is” without warranties. The information provided, including any tool-generated output, is for informational purposes only and should not be considered investment advice or guarantees. Exercise caution, seek professional advice, and make independent judgments before acting on any information found on this site.